# A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers

> **NCT04232228** · — · TERMINATED · sponsor: **Janssen-Cilag Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04232228
- **Lead sponsor:** Janssen-Cilag Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-07
- **Primary completion:** 2022-04-04
- **Final completion:** 2022-04-04
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** The Care4Today® IBD dashboard for HCPs and the patient app will be deactivated indefinitely and will no longer be available for use
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232228, "A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04232228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*